|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1Department of Physiology and Pharmacology and 2Department of Surgical Science, Karolinska Institutet, Stockholm, Sweden; 3Department of Neurology, Boston University School of Medicine, Boston; 4Mass General Institute for Neurodegenerative Disease, Massachusetts General Hospital, Boston, Massachusetts; and 5Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland
Submitted 29 July 2008 ; accepted in final form 23 November 2008
Caffeine is believed to exert its stimulant effects by blocking A2A and A1 adenosine receptors (A2AR and A1R). Although a genetic knockout of A2AR eliminates effects of caffeine, the phenotype of the knockout animal does not resemble that of caffeine treatment. In this study we explored the possibility that a mere reduction of the number of A1Rs and A2ARs, achieved by deleting one of the two copies of the A1R and A2AR genes, would mimic some aspects of long-term caffeine ingestion. The A1R and A2AR double heterozygous (A1R-A2AR dHz) mice indeed had approximately one-half the number of A1R and A2AR, and there were little compensatory changes in A2B or A3 adenosine receptor (A2BR or A3R) expression. The ability of a stable adenosine analog to activate receptors was shifted to the right by caffeine and in A1R-A2AR dHz tissue. Caffeine (0.3 g/l in drinking water for 7–10 days) and A1R-A2AR dHz genotype increased locomotor activity (LA) and decreased heart rate without significantly influencing body temperature. The acute stimulatory effect of a single injection of caffeine was reduced in A1R-A2AR dHz mice and in mice treated long term with oral caffeine. Thus at least some aspects of long-term caffeine use can be mimicked by genetic manipulation of the A1R and A2AR.
knockout; locomotor activity; tolerance; receptor binding; lipolysis
This article has been cited by other articles:
![]() |
L. Yu, J. E. Coelho, X. Zhang, Y. Fu, A. Tillman, U. Karaoz, B. B. Fredholm, Z. Weng, and J.-F. Chen Uncovering multiple molecular targets for caffeine using a drug target validation strategy combining A2A receptor knockout mice with microarray profiling Physiol Genomics, May 13, 2009; 37(3): 199 - 210. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |